Myelodysplastic Syndrome Acute Myeloid Leukemia
10 clinical trials · Condition
◉ Watch Myelodysplastic Syndrome Acute Myeloid Leukemia
| Record | Firm | Date |
|---|---|---|
| AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT05211570) | AB Science | 2022-06-01 |
| Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide (NCT04361058) | SCRI Development Innovations, LLC | 2020-04-13 |
| Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant (NCT03779854) | Fred Hutchinson Cancer Center | 2019-08-29 |
| Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT03092674) | National Cancer Institute (NCI) | 2018-02-02 |
| Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia (NCT01522976) | National Cancer Institute (NCI) | 2012-03-01 |
Track Myelodysplastic Syndrome Acute Myeloid Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.